Canary Capital has filed for what could become the United States’ first staked Injective ($INJ) exchange-traded fund (ETF).
The proposed product would not only provide investors with exposure to the volatile price action of the Injective token but also offer them a share of staking rewards, ushering in a new era for yield-generating digital asset funds in the U.S.
How the Staked Injective ETF Works
The Canary Staked INJ ETF aims to track the performance of Injective’s native token, $INJ, used to power decentralized finance (DeFi) and Web3 applications on the Injective blockchain.
What sets this ETF apart is its built-in staking component: a portion of the fund’s holdings of $INJ will be deposited into the network’s staking contracts, generating yield in the form of additional tokens over time. That yield accrues directly to shareholders, offering returns beyond simple price appreciation.
Why The Canary Capital ETF Matters
While Europe already boasts INJ and Solana ETPs that capture staking rewards, this ETF would be the very first to offer U.S. investors regulated access to both $INJ’s market performance and its staking-derived income.
Additionally, a sophisticated crypto yield mechanism might be easily accessible and tradable for institutional and popular investors, who would otherwise encounter significant obstacles when staking tokens directly.
As the U.S. crypto regulatory landscape rapidly evolves, new signals from the Securities and Exchange Commission (SEC) also suggest a more lenient approach towards staking-based ETFs, potentially opening the door for such products.
The filing follows the successful launch of the first U.S. Solana Staking ETF earlier this month, which demonstrated both heavy investor interest and the SEC’s evolving comfort with staking-based crypto funds. The agency’s current leadership has broadly signaled that staking, in this context, may fall outside the bounds of securities regulation—at least for now—offering hope to both issuers and crypto investors eager for exposure to new yield opportunities.
If approved, Canary Capital’s staked Injective (INJ) ETF will mark a historic advance for both crypto and mainstream investors, blending high-growth potential with yield, all wrapped in the security and accessibility of a U.S.-regulated ETF.
READ MORE: Dogecoin Price Prediction: DOGE is a Coiled Spring Ready to Pounce
